Healthcare Tracked since Q4 FY26 - Q4 FY26

Piramal Pharma Ltd

PIRAMALPHARMA

Latest quarter Q4 FY26

Revenue ₹2,752 Cr

Management credibility Building

Needs more scored promises across 1 quarters

Latest signal neutral

Piramal Pharma reported a transitional FY26 with revenue decline due to inventory destocking in a key on-patent comme...

Quarterly Earnings Timeline

Filing-verified financials, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q4 FY26 15 May 2026

neutral medium

Revenue ₹2,752 Cr

Piramal Pharma reported a transitional FY26 with revenue decline due to inventory destocking in a key on-patent commercial product, subdued biotech funding in H1, and...

Scorecard starts after historical backfill Read full analysis →